Related Experiment Video
Updated: Jun 30, 2026

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
Published on: June 8, 2017
Balamuthia mandrillaris Encephalitis: Slow but Lethal March Towards the Brain
Ruqaiyyah Siddiqui1,2, Sutherland K Maciver3,4, Naveed Ahmed Khan2,5
1From the Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University Edinburgh, Edinburgh, United Kingdom.
Balamuthia mandrillaris causes granulomatous amebic encephalitis, but its slow progression to brain infection remains unclear. Understanding this pathogen
Area of Science:
- Neuroparasitology
- Infectious Diseases
- Pathogenesis Research
Background:
- Balamuthia mandrillaris is an amoebic pathogen responsible for granulomatous amebic encephalitis (GAE).
- GAE is a severe neurological disease with high mortality.
- The pathogen's slow invasion of the central nervous system (CNS) contrasts with rapid neurotropic pathogens.
Purpose of the Study:
- To elucidate the mechanisms underlying the slow pathogenesis of Balamuthia mandrillaris.
- To identify potential targets for early diagnosis and novel therapeutic interventions.
- To improve the understanding of GAE development.
Main Methods:
- Literature review and synthesis of existing research on Balamuthia mandrillaris.
- Analysis of reported clinical cases and experimental studies.
- Comparative analysis with other CNS-invading pathogens.
Main Results:
- The slow progression is likely due to factors such as host immune response modulation and the pathogen's specific tropism.
- Balamuthia mandrillaris may exhibit unique strategies for evading immune surveillance within the CNS.
- Current understanding of its neuroinvasion is incomplete, hindering timely diagnosis.
Conclusions:
- The delayed onset of GAE is a critical factor influencing patient outcomes.
- Further research into Balamuthia mandrillaris's interaction with the host is crucial for developing effective treatments.
- Identifying novel therapeutic targets and improving early recognition are key priorities for managing GAE.
More Related Videos
Related Concept Videos
Arboviral Encephalitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

